Where Elevance Health Stands With Analysts
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 8 analysts have published their opinion on Elevance Health (NYSE:ELV) stock, with 3 bullish and 5 somewhat bullish ratings. The average 12-month price target is $563.12, a 0.26% decrease from the previous average of $564.57.
June 20, 2023 | 9:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Elevance Health has received 8 analyst ratings in the past 3 months, with a majority being bullish or somewhat bullish. The average 12-month price target is $563.12, slightly lower than the previous average.
The majority of the 8 analysts covering Elevance Health have a bullish or somewhat bullish outlook on the stock, indicating a positive sentiment. The average 12-month price target, although slightly lower than the previous average, still suggests potential growth in the stock price. This information is important for investors as it provides insight into the general market sentiment and potential future performance of the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100